Corticosteroids and risk of hospitalization for infection among cancer patients treated with programmed cell death receptor/ligand 1 (PD-1/PD-L1) inhibitors

被引：0
|
作者：
Sorup, Signe [1 ]
Darvalics, Bianka [1 ]
Russo, Leo [2 ]
Oksen, Dina [3 ]
Lamy, Francois-Xavier [3 ]
Verpillat, Patrice [3 ]
Sorensen, Henrik T. [1 ]
Cronin-Fenton, Deirdre [1 ]
机构：
[1] Aarhus Univ, Aarhus, Denmark
[2] Pfizer, Collegeville, PA USA
[3] Merck KGaA, Darmstadt, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
912
引用
收藏
页码：442 / 443
页数：2
相关论文
共 50 条
  • [41] Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
    Cierna, Z.
    Mego, M.
    Miskovska, V.
    Machalekova, K.
    Chovanec, M.
    Svetlovska, D.
    Hainova, K.
    Rejlekova, K.
    Macak, D.
    Spanik, S.
    Ondrus, D.
    Kajo, K.
    Mardiak, J.
    Babal, P.
    ANNALS OF ONCOLOGY, 2016, 27 (02) : 300 - 305
  • [42] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    LABORATORY INVESTIGATION, 2017, 97 : 344A - 344A
  • [43] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    MODERN PATHOLOGY, 2017, 30 : 344A - 344A
  • [44] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [45] Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer A Meta-Analysis
    Zhang, Yaxiong
    Kang, Shiyang
    Shen, Jianfei
    He, Jiaxi
    Jiang, Long
    Wang, Wei
    Guo, Zhihua
    Peng, Guilin
    Chen, Gang
    He, Jianxing
    Liang, Wenhua
    MEDICINE, 2015, 94 (06) : e515
  • [46] Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmod Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer
    Zhang, Jian
    Zhang, Huali
    Luo, Yongli
    MEDICAL SCIENCE MONITOR, 2019, 25 : 1275 - 1282
  • [47] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) expression in primary breast cancer (BC); correlations with clinical characteristics and patient outcomes.
    Vidula, Neelima
    Yau, Christina
    Goga, Andrei
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-Analysis
    Khunger, Monica
    Hernandez, Adrian V.
    Pasupuleti, Vinay
    Rakshit, Sagar
    Pennell, Nathan A.
    Stevenson, James
    Mukhopadhyay, Sanjay
    Schalper, Kurt
    Velcheti, Vamsidhar
    JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 15
  • [49] Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms
    Wang, Jen-Chin
    Chen, Chi
    Kundra, Ajay
    Kodali, Sreenath
    Pandey, Anita
    Wong, Ching
    Cheung, Tony
    Gotlieb, Vladimir
    Joseph, Gardith
    Tribie, Sophia
    LEUKEMIA RESEARCH, 2019, 79 : 52 - 59
  • [50] ANALYSIS OF PRIMARY BREAST CANCER (BC) EXPRESSION OF PROGRAMMED CELL DEATH 1 (PD-1) RECEPTOR AND PROGRAMMED DEATH LIGAND 1 (PD-L1) TO DETERMINE ASSOCIATIONS WITH CLINICAL CHARACTERISTICS AND OUTCOMES
    Vidula, Neelima
    Yau, Christina
    Goga, Andrei
    Rugo, Hope S.
    BREAST, 2015, 24 : S67 - S68
12345